Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |